FINHUB Insights

Zimmer Biomet

ZBH · Health Care · Market cap $18.3B

  1. Q1 FY25 Jan–Mar 2025
  2. Q3 FY25 Jul–Sep 2025
  3. Q4 FY25 Oct–Dec 2025
  4. Q1 FY26 Jan–Mar 2026

Q1 FY26 Jan 1 – Mar 31, 2026 reported May 1, 2026

Revenue$2.09B +9% year over year
Gross profit$1.51B
Operating profit$0.37B
Net profit$0.24B 11% margin
Sankey diagram of Zimmer Biomet's income statement for Q1 FY26
Numbers and detail
All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 2.09 100% +9%
Knees 0.83 40% +5%
SET 0.56 27% +19%
Hips 0.52 25% +6%
Technology and Data Bone Cement… 0.17 8% +15%
Cost of revenue−0.5828%
Gross profit1.5172% margin+1pp
SG&A−0.8541%+1pp
Other−0.2914%+0pp
Operating profit0.3718% margin+3pp
Tax−0.06
Interest & other costs−0.07
Net profit0.2411%+2pp

Filing on EDGAR · This quarter on its own page

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter Period Reported Revenue Year over year Operating margin Net profit Net margin
Q1 FY26 Jan 1 – Mar 31, 2026 May 1, 2026 $2.1B +9% 18% $0.24B 11%
Q4 FY25 Oct 1 – Dec 31, 2025 Feb 20, 2026 $2.2B +11% 7% $0.14B 6%
Q3 FY25 Jul 1 – Sep 30, 2025 Nov 5, 2025 $2.0B +10% 18% $0.23B 12%
Q1 FY25 Jan 1 – Mar 31, 2025 May 5, 2025 $1.9B +1% 15% $0.18B 10%